Cargando…
Enhanced expression of PD-L1 in non-muscle-invasive bladder cancer after treatment with Bacillus Calmette-Guerin
Immune checkpoint molecules, such as PD-1/PD-L1, are reported to be closely associated with suppression of antitumor immunity, and their inhibitors have been used to treat various cancers including bladder cancer. However, there have been only a few studies investigating the effects of Bacillus Calm...
Autores principales: | Hashizume, Akihito, Umemoto, Susumu, Yokose, Tomoyuki, Nakamura, Yoshiyasu, Yoshihara, Mitsuyo, Shoji, Kahori, Wada, Satoshi, Miyagi, Yohei, Kishida, Takeshi, Sasada, Tetsuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183350/ https://www.ncbi.nlm.nih.gov/pubmed/30344922 http://dx.doi.org/10.18632/oncotarget.26122 |
Ejemplares similares
-
Bacillus Calmette–Guérin Immunotherapy for Cancer
por: Cardillo, Fabíola, et al.
Publicado: (2021) -
VARIABILITY OF BCG STRAINS (BACILLUS CALMETTE-GUÉRIN)
por: Suter, W. Emanuel, et al.
Publicado: (1951) -
Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency
por: Bernatowska, Ewa Anna, et al.
Publicado: (2007) -
Bacillus Calmette-Guerin (BCG) vaccine in Iran
por: Fallah, Fatemeh, et al.
Publicado: (2018) -
Bacillus Calmette-Guerin (BCG): the adroit vaccine
por: Adesanya, Oluwafolajimi A., et al.
Publicado: (2021)